• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

SNORA21 表达上调,作为一种新的独立指标,可用于预测人类胃癌的预后。

The SNORA21 expression is upregulated and acts as a novel independent indicator in human gastric cancer prognosis.

机构信息

Department of Medical Oncology, Affiliated Hospital of Inner Mongolia Medical University, Hohhot City, Inner Mongolia Autonomous Region, P.R. China.

出版信息

Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5519-5524. doi: 10.26355/eurrev_201809_15812.

DOI:10.26355/eurrev_201809_15812
PMID:30229823
Abstract

OBJECTIVE

Emerging evidence indicates that small nucleolar RNAs (snoRNAs) act crucial roles in oncogenesis. Herein, the aim of this study is to investigate the clinical value of SNORA21 expression in gastric cancer (GC).

PATIENTS AND METHODS

The expression of SNORA21 was determined in 79 cases of GC tissues and adjacent normal tissues by quantitative Real-Time Polymerase Chain Reaction (qRT-PCR) analysis. The association between SNORA21 expression and clinicopathological features was analyzed by the chi-square test. The survival curves were calculated by the Kaplan-Meier method and log-rank test. Univariate and multivariate analyses were used to assess the prognostic value of SNORA21 expression.

RESULTS

Our results first demonstrated that SNORA21 expression was significantly upregulated in human GC tissues and cells compared to their corresponding adjacent normal tissues and GES-1 cells, respectively (p<0.05). Furthermore, elevated SNORA21 expression was significantly associated with distant metastasis (p<0.05) and lymph node metastasis (p<0.05) in GC patients. Kaplan-Meier survival plots demonstrated that higher SNORA21 expression was associated with poor disease-free survival (DFS) and overall survival (OS) rate, respectively. Univariate analysis and multivariate regression analysis indicated that a higher SNORA21 was an independent risk factor for prognosis in GC patients.

CONCLUSIONS

The current results indicate that SNORA21 expression may be served as a predictor of GC prognosis.

摘要

目的

新兴证据表明,小核仁 RNA(snoRNA)在肿瘤发生中发挥关键作用。本研究旨在探讨 SNORA21 在胃癌(GC)中的表达的临床价值。

方法

通过定量实时聚合酶链反应(qRT-PCR)分析,检测 79 例 GC 组织和相邻正常组织中 SNORA21 的表达。采用卡方检验分析 SNORA21 表达与临床病理特征的关系。采用 Kaplan-Meier 法和对数秩检验计算生存曲线。采用单因素和多因素分析评估 SNORA21 表达的预后价值。

结果

我们的研究结果首次表明,与相应的相邻正常组织和 GES-1 细胞相比,SNORA21 在人 GC 组织和细胞中的表达明显上调(p<0.05)。此外,SNORA21 的高表达与 GC 患者的远处转移(p<0.05)和淋巴结转移(p<0.05)显著相关。Kaplan-Meier 生存曲线表明,SNORA21 表达水平越高,患者的无病生存(DFS)和总生存(OS)率越低。单因素和多因素回归分析表明,SNORA21 高表达是 GC 患者预后的独立危险因素。

结论

本研究结果表明,SNORA21 表达可能作为 GC 预后的预测指标。

相似文献

1
The SNORA21 expression is upregulated and acts as a novel independent indicator in human gastric cancer prognosis.SNORA21 表达上调,作为一种新的独立指标,可用于预测人类胃癌的预后。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5519-5524. doi: 10.26355/eurrev_201809_15812.
2
SNORA21 - An Oncogenic Small Nucleolar RNA, with a Prognostic Biomarker Potential in Human Colorectal Cancer.SNORA21-一种致癌性的小核仁 RNA,在人类结直肠癌中具有潜在的预后生物标志物。
EBioMedicine. 2017 Aug;22:68-77. doi: 10.1016/j.ebiom.2017.07.009. Epub 2017 Jul 12.
3
Expression of miR-1294 is downregulated and predicts a poor prognosis in gastric cancer.miR-1294 的表达下调预示着胃癌预后不良。
Eur Rev Med Pharmacol Sci. 2018 Sep;22(17):5525-5530. doi: 10.26355/eurrev_201809_15813.
4
H19 serves as a diagnostic biomarker and up-regulation of H19 expression contributes to poor prognosis in patients with gastric cancer.H19 可作为诊断生物标志物,H19 表达上调与胃癌患者预后不良有关。
Neoplasma. 2016;63(2):223-30. doi: 10.4149/207_150821N454.
5
The prognostic roles of long non-coding RNA SNHG17 in the patients with gastric cancer.长链非编码 RNA SNHG17 在胃癌患者中的预后作用。
Eur Rev Med Pharmacol Sci. 2019 Feb;23(3):1063-1068. doi: 10.26355/eurrev_201902_16994.
6
Elevated long non-coding RNA LINC00958 was associated with metastasis and unfavorable prognosis in gastric cancer.长链非编码 RNA LINC00958 升高与胃癌转移和不良预后相关。
Eur Rev Med Pharmacol Sci. 2019 Jan;23(2):598-603. doi: 10.26355/eurrev_201901_16872.
7
Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.成纤维细胞生长因子受体4蛋白表达与胃癌的临床病理特征
World J Gastroenterol. 2015 Feb 14;21(6):1838-44. doi: 10.3748/wjg.v21.i6.1838.
8
High expression of CD11c indicates favorable prognosis in patients with gastric cancer.CD11c的高表达表明胃癌患者预后良好。
World J Gastroenterol. 2015 Aug 21;21(31):9403-12. doi: 10.3748/wjg.v21.i31.9403.
9
Low level of FOXL1 indicates a worse prognosis for gastric cancer patients.FOXL1水平低表明胃癌患者预后较差。
Tumour Biol. 2016 Aug;37(8):11331-7. doi: 10.1007/s13277-016-4890-8. Epub 2016 Mar 9.
10
Long non-coding RNA CARLo-5 upregulation associates with poor prognosis in patients suffering gastric cancer.长链非编码RNA CARLo-5的上调与胃癌患者的不良预后相关。
Eur Rev Med Pharmacol Sci. 2017 Feb;21(3):530-534.

引用本文的文献

1
Functional impact of the hyperduplication genomophenotype in high copy number endometrial cancer.高拷贝数子宫内膜癌中基因表型超复制的功能影响
iScience. 2025 Jun 7;28(7):112850. doi: 10.1016/j.isci.2025.112850. eCollection 2025 Jul 18.
2
Emerging role of small RNAs in inflammatory bowel disease and associated colorectal cancer (Review).小RNA在炎症性肠病及相关结直肠癌中的新作用(综述)
Int J Mol Med. 2025 Feb;55(2). doi: 10.3892/ijmm.2024.5474. Epub 2024 Dec 20.
3
The pharmacogenomic and immune landscape of snoRNAs in human cancers.
snoRNAs 在人类癌症中的药物基因组学和免疫全景。
Cancer Lett. 2024 Nov 28;605:217304. doi: 10.1016/j.canlet.2024.217304. Epub 2024 Oct 18.
4
The diagnostic value of serum exosomal SNORD116 and SNORA21 for NSCLC patients.血清外泌体 SNORD116 和 SNORA21 对非小细胞肺癌患者的诊断价值。
Clin Transl Oncol. 2025 Feb;27(2):650-659. doi: 10.1007/s12094-024-03606-1. Epub 2024 Jul 17.
5
Small Nucleolar RNAs as Diagnostic and Prognostic Biomarkers in Cancer: A Systematic Review and Meta-Analysis.小核仁 RNA 作为癌症诊断和预后生物标志物的系统评价和荟萃分析。
Technol Cancer Res Treat. 2024 Jan-Dec;23:15330338241245939. doi: 10.1177/15330338241245939.
6
Knowledge mapping and current trends of global research on snoRNA in the field of cancer.癌症领域中snoRNA的全球研究知识图谱及当前趋势
J Cancer. 2023 Aug 21;14(14):2596-2607. doi: 10.7150/jca.87196. eCollection 2023.
7
The emerging role of snoRNAs in human disease.小核仁RNA在人类疾病中的新作用。
Genes Dis. 2022 Dec 26;10(5):2064-2081. doi: 10.1016/j.gendis.2022.11.018. eCollection 2023 Sep.
8
Cancer metastasis under the magnifying glass of epigenetics and epitranscriptomics.癌症转移的表观遗传学和转录后组学研究。
Cancer Metastasis Rev. 2023 Dec;42(4):1071-1112. doi: 10.1007/s10555-023-10120-3. Epub 2023 Jun 28.
9
SNHG25 facilitates SNORA50C accumulation to stabilize HDAC1 in neuroblastoma cells.SNHG25 促进 SNORA50C 的积累,从而稳定神经母细胞瘤细胞中的 HDAC1。
Cell Death Dis. 2022 Jul 11;13(7):597. doi: 10.1038/s41419-022-05040-z.
10
The Potential Role of Small Nucleolar RNAs in Cancers - An Evidence Map.小核仁RNA在癌症中的潜在作用——证据图谱
Int J Gen Med. 2022 Apr 8;15:3851-3864. doi: 10.2147/IJGM.S352333. eCollection 2022.